MyD88-dependent pathways play an important role in the development of diabetes-induced inflammation in the retina, and inhibition of MyD88 might be a novel target to inhibit early abnormalities of diabetic retinopathy and perhaps other complications of diabetes. This evidence concerns the gene MYD88 and diabetic retinopathy.